Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development.

Kang X, Qi Y, Zuo Y, Wang Q, Zou Y, Schwartz RJ, Cheng J, Yeh ET.

Mol Cell. 2010 Apr 23;38(2):191-201. doi: 10.1016/j.molcel.2010.03.005.

PMID:
20417598
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress.

Han Y, Huang C, Sun X, Xiang B, Wang M, Yeh ET, Chen Y, Li H, Shi G, Cang H, Sun Y, Wang J, Wang W, Gao F, Yi J.

J Biol Chem. 2010 Apr 23;285(17):12906-15. doi: 10.1074/jbc.M109.071431. Epub 2010 Feb 24.

PMID:
20181954
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential.

Mooney SM, Grande JP, Salisbury JL, Janknecht R.

Biochemistry. 2010 Jan 12;49(1):1-10. doi: 10.1021/bi901263m.

PMID:
19995069
[PubMed - indexed for MEDLINE]
4.

The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome.

Driscoll JJ, Pelluru D, Lefkimmiatis K, Fulciniti M, Prabhala RH, Greipp PR, Barlogie B, Tai YT, Anderson KC, Shaughnessy JD Jr, Annunziata CM, Munshi NC.

Blood. 2010 Apr 8;115(14):2827-34. doi: 10.1182/blood-2009-03-211045. Epub 2009 Nov 30.

PMID:
19965618
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation.

Huang C, Han Y, Wang Y, Sun X, Yan S, Yeh ET, Chen Y, Cang H, Li H, Shi G, Cheng J, Tang X, Yi J.

EMBO J. 2009 Sep 16;28(18):2748-62. doi: 10.1038/emboj.2009.210. Epub 2009 Aug 13.

PMID:
19680224
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

SUMO-specific protease 2 is essential for modulating p53-Mdm2 in development of trophoblast stem cell niches and lineages.

Chiu SY, Asai N, Costantini F, Hsu W.

PLoS Biol. 2008 Dec 16;6(12):e310. doi: 10.1371/journal.pbio.0060310.

PMID:
19090619
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The fast-growing business of SUMO chains.

Ulrich HD.

Mol Cell. 2008 Nov 7;32(3):301-5. doi: 10.1016/j.molcel.2008.10.010. Review.

PMID:
18995828
[PubMed - indexed for MEDLINE]
Free Article
8.

Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3.

Kuo ML, den Besten W, Thomas MC, Sherr CJ.

Cell Cycle. 2008 Nov 1;7(21):3378-87. Epub 2008 Nov 4.

PMID:
18948745
[PubMed - indexed for MEDLINE]
Free Article
9.

Proteomic characterization of mouse cytosolic and membrane prostate fractions: high levels of free SUMO peptides are androgen-regulated.

Caron D, Winstall E, Inaguma Y, Michaud S, Lettre F, Bourassa S, Kelly I, Poirier GG, Faure RL, Tanguay RM.

J Proteome Res. 2008 Oct;7(10):4492-9. doi: 10.1021/pr8002497. Epub 2008 Aug 27.

PMID:
18729496
[PubMed - indexed for MEDLINE]
10.

SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia.

Cheng J, Kang X, Zhang S, Yeh ET.

Cell. 2007 Nov 2;131(3):584-95.

PMID:
17981124
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells.

Bawa-Khalfe T, Cheng J, Wang Z, Yeh ET.

J Biol Chem. 2007 Dec 28;282(52):37341-9. Epub 2007 Oct 11.

PMID:
17932034
[PubMed - indexed for MEDLINE]
Free Article
12.

SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas.

Moschos SJ, Smith AP, Mandic M, Athanassiou C, Watson-Hurst K, Jukic DM, Edington HD, Kirkwood JM, Becker D.

Oncogene. 2007 Jun 21;26(29):4216-25. Epub 2007 Feb 12.

PMID:
17297476
[PubMed - indexed for MEDLINE]
13.

A fluorescence-resonance-energy-transfer-based protease activity assay and its use to monitor paralog-specific small ubiquitin-like modifier processing.

Martin SF, Hattersley N, Samuel ID, Hay RT, Tatham MH.

Anal Biochem. 2007 Apr 1;363(1):83-90. Epub 2007 Jan 4.

PMID:
17288980
[PubMed - indexed for MEDLINE]
14.

The regulation of INK4/ARF in cancer and aging.

Kim WY, Sharpless NE.

Cell. 2006 Oct 20;127(2):265-75. Review.

PMID:
17055429
[PubMed - indexed for MEDLINE]
Free Article
15.

Role of desumoylation in the development of prostate cancer.

Cheng J, Bawa T, Lee P, Gong L, Yeh ET.

Neoplasia. 2006 Aug;8(8):667-76. Review.

PMID:
16925949
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The SUMO-specific protease SENP5 is required for cell division.

Di Bacco A, Ouyang J, Lee HY, Catic A, Ploegh H, Gill G.

Mol Cell Biol. 2006 Jun;26(12):4489-98.

PMID:
16738315
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice.

Nacerddine K, Lehembre F, Bhaumik M, Artus J, Cohen-Tannoudji M, Babinet C, Pandolfi PP, Dejean A.

Dev Cell. 2005 Dec;9(6):769-79.

PMID:
16326389
[PubMed - indexed for MEDLINE]
Free Article
18.

A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation.

Owerbach D, McKay EM, Yeh ET, Gabbay KH, Bohren KM.

Biochem Biophys Res Commun. 2005 Nov 18;337(2):517-20. Epub 2005 Sep 22.

PMID:
16198310
[PubMed - indexed for MEDLINE]
19.

A role for Ubc9 in tumorigenesis.

Mo YY, Yu Y, Theodosiou E, Ee PL, Beck WT.

Oncogene. 2005 Apr 14;24(16):2677-83.

PMID:
15735760
[PubMed - indexed for MEDLINE]
20.

Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases.

Cheng J, Perkins ND, Yeh ET.

J Biol Chem. 2005 Apr 15;280(15):14492-8. Epub 2005 Feb 8.

PMID:
15701643
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk